Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 
   

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* BURGOYNE CELESTE (Last) (First) (Middle) C/O LULULEMON ATHLETICA INC 1818 CORNWALL AVENUE (Street) VANCOUVER A1 V6J 1C7 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol lululemon athletica inc. [ LULU ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Pres Americas & Global Guest
	3. Date of Earliest Transaction (Month/Day/Year) 12/09/2024
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2024		M		8,652	A	$167.54	23,381	D
Common Stock	12/09/2024		M		7,865	A	$188.84	31,246	D
Common Stock	12/09/2024		M		6,053	A	$306.71	37,299	D
Common Stock	12/09/2024		S		1,749	D	$400.28(1)	35,550	D
Common Stock	12/09/2024		S		730	D	$401.42(2)	34,820	D
Common Stock	12/09/2024		S		3,727	D	$402.31(3)	31,093	D
Common Stock	12/09/2024		S		3,235	D	$404.46(4)	27,858	D
Common Stock	12/09/2024		S		4,278	D	$405.73(5)	23,580	D
Common Stock	12/09/2024		S		3,421	D	$406.62(6)	20,159	D
Common Stock	12/09/2024		S		1,173	D	$407.51(7)	18,986	D
Common Stock	12/09/2024		S		4,598	D	$408.33(8)	14,388	D
Common Stock	12/09/2024		S		1,959	D	$409.64(9)	12,429	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$167.54	12/09/2024		M			8,652	(10)	03/28/2026	Common Stock	8,652	$0	0	D
Stock Option (right to buy)	$188.84	12/09/2024		M			7,865	(11)	03/27/2027	Common Stock	7,865	$0	0	D
Stock Option (right to buy)	$306.71	12/09/2024		M			6,053	(12)	03/31/2028	Common Stock	6,053	$0	2,017	D

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.00 to $400.985, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges stated in footnotes (1) through (9) to this Form 4.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.01 to $402.00, inclusive.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.01 to $403.00, inclusive.

4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.075 to $405.00, inclusive.

5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $405.175 to $406.00, inclusive.

6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.10 to $407.00, inclusive.

7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.02 to $407.77, inclusive.

8. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $408.03 to $408.52, inclusive.

9. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.095 to $410.035, inclusive.

10. These options vested with respect to 25% on each of March 28, 2020, March 28, 2021, March 28, 2022 and March 28, 2023.

11. These options vested with respect to 25% on each of March 27, 2021, March 27, 2022, March 27, 2023 and March 27, 2024.

12. These options vested with respect to 25% on each of March 31, 2022, March 31, 2023 and March 31, 2024 and will vest with respect to 25% on March 31, 2025.

	/s/ Celeste Burgoyne by Alex Grieve, Attorney-in-Fact	12/11/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

---